Multi-drug ligand conjugates

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01)

Patent

CA 2617660

Described herein are compounds, pharmaceutical compositions and methods for treating pathogenic cell populations in a patient. The compounds described herein include conjugates of a plurality of cytotoxic drugs and vitamin receptor binding ligands. The plurality of drugs may be the same or different. Similarly, the vitamin receptor binding ligands may be the same or different. The conjugates also include a linker that is formed from one or more spacer linkers, heteroatom linkers, and releasable linkers.

La présente invention concerne des composés, des compositions pharmaceutiques et des techniques de traitement de populations de cellules pathogènes chez un patient. Les composés de l'invention comprennent des conjugués d'une pluralité de médicaments cytotoxiques et de ligands de liaison aux récepteurs de vitamine. La pluralité de ces médicaments peuvent être semblables ou différents. De la même façon, les ligands se liant aux récepteurs de vitamine peuvent être semblables ou différents. Les conjugués comprennent aussi un lieur qui est formé à partir d'un ou de plusieurs lieurs espaceur, de lieurs d'hétéroatome et de lieurs pouvant être libérés..

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Multi-drug ligand conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multi-drug ligand conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-drug ligand conjugates will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1995101

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.